An autosomal recessive nonsyndromic deafness that has material basis in variation in the chromosome region 2q23-q31.
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
The documentation for autosomal recessive nonsyndromic hearing loss 27 is limited due to its rarity and the fact that it affects fewer individuals, leading to fewer systematic studies. Additionally, the genetic basis of this condition has not been fully characterized, which complicates clinical understanding and documentation. Ongoing research may eventually provide more insights into its clinical features and management.
To navigate your care for autosomal recessive nonsyndromic hearing loss 27, consider consulting with an audiologist who specializes in genetic hearing loss. Genetic counseling may also be beneficial, especially to discuss family planning and the implications of autosomal recessive inheritance. While there are no specific patient organizations identified for this condition, resources such as the Genetic and Rare Diseases Information Center (GARD) can provide valuable information. You can access GARD at rarediseases.info.nih.gov for further support and information on genetic counseling.
Currently, there is one active clinical trial related to autosomal recessive nonsyndromic hearing loss 27. You can explore this trial and its details by visiting ClinicalTrials.gov at the following link: https://clinicaltrials.gov/search?cond=autosomal%20recessive%20nonsyndromic%20hearing%20loss%2027. While there are no orphan drugs designated for this condition, participation in clinical trials may provide access to new treatment strategies and contribute to the understanding of this disorder.
Actionable guidance for navigating care for autosomal recessive nonsyndromic hearing loss 27
To navigate your care for autosomal recessive nonsyndromic hearing loss 27, consider consulting with an audiologist who specializes in genetic hearing loss. Genetic counseling may also be beneficial, especially to discuss family planning and the implications of autosomal recessive inheritance. While there are no specific patient organizations identified for this condition, resources such as the Genetic and Rare Diseases Information Center (GARD) can provide valuable information. You can access GARD at rarediseases.info.nih.gov for further support and information on genetic counseling.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.